mGlu3 receptor program (Addex/Pierre Fabre)
N/A
Report date: 2025/03/20 15:50:31
NME
Base Information
Drug NamemGlu3 receptor program (Addex/Pierre Fabre)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAddex Therapeutics Ltd
Inactive CompaniesPierre Fabre Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A